Christopher V Vitale
First SEC filing: Dec. 13, 2013 · Latest: Dec. 13, 2013
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| July 13, 2026 | AXR | A | 8,700 | · | · | 125,900 Direct | +7.42% | Acquired | (price as of 2026-10-02) |
| July 17, 2025 | AXR | A | 8,000 | · | · | 117,200 Direct | +7.33% | Acquired | (price as of 2026-10-02) |
| July 18, 2024 | AXR | A | 7,200 | · | · | 109,200 Direct | +7.06% | Acquired | (price as of 2026-10-02) |
| July 12, 2023 | AXR | A | 8,000 | · | · | 102,000 Direct | +8.51% | Acquired | (price as of 2026-10-02) |
| July 13, 2022 | AXR | A | 8,000 | · | · | 94,000 Direct | +9.30% | Acquired | (price as of 2026-10-02) |
| Nov. 1, 2021 | AXR | A | 50,000 | · | · | 50,000 Direct | · | Acquired | (price as of 2026-10-02) |
| July 7, 2021 | AXR | A | 6,000 | · | · | 86,000 Direct | +7.50% | Acquired | (price as of 2026-10-02) |
| July 17, 2020 | AXR | A | 6,000 | · | · | 80,000 Direct | +8.11% | Acquired | (price as of 2026-10-02) |
| July 11, 2019 | AXR | A | 7,500 | · | · | 74,000 Direct | +11.28% | Acquired | (price as of 2026-10-02) |
| July 10, 2018 | AXR | A | 25,000 | · | · | 66,500 Direct | +60.24% | Acquired | (price as of 2026-10-02) |
| Sept. 14, 2017 | AXR | A | 10,000 | · | · | 41,500 Direct | +31.75% | Acquired | (price as of 2026-10-02) |
| June 21, 2017 | AXR | A | 6,000 | · | · | 31,500 Direct | +23.53% | Acquired | (price as of 2026-10-02) |
| June 21, 2016 | AXR | A | 7,500 | · | · | 25,500 Direct | +41.67% | Acquired | (price as of 2026-10-02) |
| July 13, 2015 | AXR | A | 3,000 | · | · | 18,000 Direct | +20.00% | Acquired | (price as of 2026-10-02) |
| July 8, 2014 | AXR | A | 6,000 | · | · | 15,000 Direct | +66.67% | Acquired | (price as of 2026-10-02) |
| Dec. 11, 2013 | AXR | A | 9,000 | · | · | 9,000 Direct | · | Acquired | (price as of 2026-10-02) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Nov. 1, 2021 | AXR | Stock option (right to buy) | Common stock, $.10 par value | $14.24 | Nov. 1, 2031 | 50,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2020 | · | · | · | · | · | · | · | · |
| 2019 | $318,269 | · | $176,250 | · | · | · | $322 | $494,841 |
| 2018 | $275,205 | · | $110,820 | · | · | · | $270 | $386,295 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.